Pegylation and cell based bioassay of human interferon- α2b along its docking studies and effect on plasma half-life.
CONCLUSION: Thus, IFN-Ald40K with 12% residual activity and 62 hours of serum half-life proved to be a potent anticancerous and antiviral drug with enhanced serum retention time.
PMID: 31612813 [PubMed - as supplied by publisher]
Source: Protein and Peptide Letters - Category: Biochemistry Authors: Shahzadi SK, Qadir MA, Mahmood N, Ahmed M Tags: Protein Pept Lett Source Type: research
More News: Biochemistry | Cancer & Oncology | Carcinoma | Chronic Leukemia | Chronic Myeloid Leukaemia | Hairy Cell Leukemia | HIV AIDS | Leukemia | Melanoma | Molecular Biology | Polyethylene Glycol | Skin Cancer | Study